Integrated Performance Report 26 October 2017

Slides:



Advertisements
Similar presentations
The Emergency Centre Rotherham CCG Sarah Lever – Head of Contracts & Service Improvement Joanne Martin – Urgent Care Review Project Lead.
Advertisements

Reinventing Cancer Support Ciarán Devane Chief Executive.
CCG Assurance Framework Scorecard 2014/15 – Month 1 Sandra Iskander.
Acute Oncology Service (AOS) Monday – Friday 8am – 4pm Bleep: 946 T: x5726 F: Dr Nicola Beech Dr Jillian Noble Dr Susannah.
Preparing for Winter 2010/11 Guidance Overview Stuart Low Planning Manager SG Health Delivery Directorate.
Unscheduled Care Winter Workshop 2013/14 Winter Analysis & Preparing for Winter 2014/15 Stirling Management Centre 11 Sept 2014.
Council of Governors Meeting Elaine Hobson Chief Operating Officer January 2010, Item 7 Relates to Domain 1 (C4a) and Domain 5 (C18, C19)
Delivering clinical research to make patients, and the NHS, better Haematological Cancer Research Report Site Specific Group Meeting Tuesday 14 th October.
Stirling Management Centre 11 th September 2014 Unscheduled Care National Event Learning Workshop.
Preparing for Winter 2011/12 Guidance Overview Stuart Low Planning Manager Scottish Govt NHSScotland Business & Performance Mgt Team.
Cancer Outcomes and Services Dataset Linda Wintersgill Information & Audit Manager, NECN.
CHILDREN AND YOUNG PEOPLE’S HEALTH SUPPORT GROUP Unscheduled Care Helen Maitland National Lead.
Facilitating tissue collection for translational research Jane Rogan Business Manager.
Faster Cancer Treatment (FCT) - Improving quality of care across the patient cancer pathway Update Aug 2012.
Healthy Liverpool. Five areas of transformation “Not just physical activity, other factors have to be considered, loneliness, deprivation, housing conditions,
Paul Sutton, Chief Executive Reviewing 2014/15 and looking forwards.
MEDICINE: Emergency Medicine /Acute Medicine/Stroke/Care Of The Elderly/ Rheumatology/ Neurology/ Nephrology/Endocrinology/ Infectious Diseases/ Cardiology/
Clinical Networks South Tyneside Health Care NHSTrust.
Macmillan Ipswich Diagnostic Assessment Service (MIDAS)
Corporate Performance Report December 2012
2 November John Childs and Deborah Woodley
Governing Body 24 January 2017
TCST Optimising Diagnostics Action Learning Event
Operations Executive Director of Operations
Genomic Medicine Centre Overview
Emergency and Unscheduled Care Right patient, right place, first time Update to Trust Board 3 June
SWAG SSG Colorectal Cancer Meeting
CNC Orientation Forum May 2013
Cancer e-Referrals Imogen Staveley
Cancer 62 day rapid recovery plan South region
SWAG SSG Urology Cancer Meeting
SWAG SSG Upper GI Cancer Meeting
West Middlesex Hospital
West of England Genomic Medicine Centre: Our Progress to Date
Pathway for patients with suspected Breast Cancer
Shrewsbury & Telford NHS Trust Sustainable Services Programme Update Mid Wales Healthcare Collective -12th March 2018.
Local networking sessions
15/16 Achievements and ambition for 16/17
Finance Update.
Cancer Waiting Times Standards
Planning Update – HealthNet
User guide 62 day waiting time model
Pathway for patients with suspected Upper GI (OG) Cancer
SWAG SSG Urology Meeting
SWAG SSG Gynaecological Cancers Meeting
Early Diagnosis Diagnostics Cancer Waits Survivorship South West Cancer Network 14 November 2014.
Patient Reference Group
CCG Assurance Framework Scorecard
Governing Body Quality Update
SWAG SSG Breast Cancer Meeting
SWAG SSG Sarcoma Meeting
Finance Update October 2018/19.
Harrogate and District NHS Foundation Trust
SWAG SSG Head and neck Cancer Meeting
Patient and Public Council Winter Review and DToCs
SWAG SSG Sarcoma Cancer Meeting
SWAG SSG Lung Cancer Meeting
SWAG SSG Haematology and Lymphoma Cancer Meeting
SWAG SSG Lung Cancer Meeting
Quality Impact Assessment Unscheduled Care Group Board 25 October 2018
SWAG SSG Skin Cancer Meeting
Pathway for patients with suspected Breast Cancer
28 Day Faster Diagnosis Standard
SWAG SSG Breast Cancer Meeting
SWAG SSG Upper GI Cancer Meeting
Lung Cancer Clinical Advisory Group
Integrated Performance Report
Calderdale and Huddersfield NHS Foundation Trust
Somerset, Wiltshire, Avon & Gloucestershire Cancer Alliance
Walsall RTT Recovery Summary
Presentation transcript:

Integrated Performance Report 26 October 2017 Caroline Shaw Chief Operating Officer

Strong performance

Standards not consistently achieving

Areas requiring improvement

Cancer 62 day standard (1/4) Aug - 84.3% adjusted (1 breach above target) - 79.8% unadjusted (7.5 breaches above target)

Cancer 62 day standard (2/4) Backlog targets in place across all tumour sites 104 day breaches at an all time low

Cancer 62 day standard (3/4) August 2017 adjusted: 22.5 breaches out of 143.5 treatments (84.3%) Table shows breach tolerance at tumour site level *to nearest 0.5 breach Breaches Treatments Adjusted Performance Breaches above 85%* Lung 7 25 72% 3.5 Urology 6 28.5 78.9% 2 Head & Neck 4 12 66.7% 2.5 Lower Gastrointestinal 1.5 14.5 89.7% Upper Gastrointestinal 1 13.5 92.6% Gynaecology 8.5 88.2% Breast 96% Other 0% Sarcoma 3 100% Skin Haematology 9 Total 22.5 143.5 84.3%

Cancer 62 day standard (4/4) Key actions Ambulatory pathway for Lung biopsies (Oct) FIT (faecal immunochemical tests) roll-out in Lower GI (end of Oct) One stop service in Head & Neck (Nov) Additional all day theatre list in Urology (Nov) Prostate slots returned from Treatment Centre (will reduce late tertiaries) Monthly provider meetings focussing on timely tertiary referrals & weekly virtual PTLs (Oct)

Emergency access within 4 hours (1/2) Sept 82.7% Sept adjusted performance with Urgent Care Centre 86%

Emergency access within 4 hours (2/2) Key actions Combined performance with Urgent Care Centre (Nov) Working practices in ED (Nov/Dec) Full Capacity Protocol (Oct) Discharge to Assess (Oct onwards) Weekly A&E Delivery Boards (Oct) Reconfigure assessment areas (Dec)

Winter readiness Actions Flu jab campaign (in place) Divisional Christmas & New Year plans (Nov) Additional respiratory beds (Dec) Clinically-led escalation plans

Key messages Strong performance in friends and family, diagnostic waits, referral to treatment and key patient safety and experience indicators We continue to focus considerable effort on delivering and sustaining required performance for the cancer 62 day and the emergency access standards Preparations for winter advancing well